Patients with a chronic cough that persists even after treatment usually see a few specialists and have lingering triggers that cause their cough, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Patients with a chronic cough that persists even after treatment usually see a few specialists and have lingering triggers that cause their cough, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
How is chronic cough typically diagnosed and evaluated?
The basic definition of a chronic cough is a cough that you've had for over 8 weeks. So, in that regard, it's a really easy diagnosis and primary care physicians diagnose it all the time.
The type of cough that I treat is referred to as a few different names. It's usually called refractory chronic cough or unexplained chronic cough or difficult-to-treat chronic cough. And those all mean pretty similar things. And really, they just have already gone through primary care, and probably seen a few specialists, and they're still coughing, despite assessing for different things like reflux, post-nasal drip, those types of things, and even treating for those things.
And so, once they get to me, as a speech pathologist, they've already gone through a gamut of testing and trials of different medications and treatments that have either helped some but not completely or haven't helped at all.
And most of these patients have what we call cough hypersensitivity syndrome. And so even though the cough started, usually with something else, whether it was a viral upper respiratory infection, or chronic reflux, or just a chronic cough–inducing illness, like bronchitis, those are the things that usually kind of start the cough, but then the hypersensitivity that results from that is prolonged and we believe it's perpetuated by the cough itself.
So, you can treat all the underlying causes, but if you now have increased triggers, other than that cause, every time you cough in response to that trigger, you're just continuing it. So, when I'm diagnosing a patient, I'm really looking for symptoms of cough hypersensitivity because that's specifically what we treat. So, things like do they cough to strong smells like perfumes laundry soaps? Cold air is a common trigger. Talking and laughing are common triggers in patients with cough hypersensitivity. And it's generally a dry cough.
So those are the big things that we're looking at.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More